The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 30, 2024
Filed:
Jun. 07, 2021
Applicant:
Axcess Global Sciences, Llc, Salt Lake City, UT (US);
Inventors:
Assignee:
AXCESS GLOBAL SCIENCES, LLC, Salt Lake City, UT (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4355 (2006.01); A61K 9/107 (2006.01); A61K 31/00 (2006.01); A61K 31/19 (2006.01); A61K 31/4745 (2006.01); A61K 36/889 (2006.01); A61K 45/06 (2006.01); A61K 47/44 (2017.01); A61K 47/69 (2017.01); A61P 3/08 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4355 (2013.01); A61K 9/1075 (2013.01); A61K 31/00 (2013.01); A61K 31/19 (2013.01); A61K 31/4745 (2013.01); A61K 36/889 (2013.01); A61K 45/06 (2013.01); A61K 47/44 (2013.01); A61K 47/6911 (2017.08); A61P 3/08 (2018.01); A61K 9/0053 (2013.01);
Abstract
In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.